Management of heartburn: cost considerations.
Vakil
N
N
University of Wisconsin Medical School, Milwaukee, WI, USA.
D000863:Antacids / Q000191:economics* / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000191:economics* / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D016145:Endoscopy, Digestive System / Q000191:economics*; D005764:Gastroesophageal Reflux / Q000150:complications / Q000191:economics / Q000628:therapy; D017048:Health Care Costs; D006356:Heartburn / Q000191:economics* / Q000209:etiology / Q000628:therapy; D006635:Histamine H2 Antagonists / Q000191:economics* / Q000627:therapeutic use; D006801:Humans; D011320:Primary Health Care / Q000191:economics*; D014481:United States
D000863:Antacids; D000897:Anti-Ulcer Agents; D006635:Histamine H2 Antagonists